Global Meglumine Market Strategic Research Report

Scope of the Report

The global Meglumine market size is predicted to grow from US$ 11.47 million in 2025 to US$ 15.06 million in 2032; it is expected to grow at a CAGR of 4.0% from 2026 to 2032.

Meglumine is a white crystalline powder. Melting point 128-129°C. Soluble in water, slightly soluble in ethanol, almost insoluble in chloroform. Taste sweet and salty astringent. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-132ºC and the boiling point is 490.4ºC at 760 mmHg. Meglumine is an amino sugar derived from glucose.

In 2024, global Meglumine production reached approximately 352 MT, with an average global market price of around US$ 29 per KG.

The meglumine market is a niche segment within the pharmaceutical and medical chemical industry, primarily driven by its role as an excipient and stabilizing agent in the formulation of injectable drugs, contrast media, and other therapeutic solutions. Its demand is closely tied to the growth of the pharmaceutical sector, diagnostic imaging procedures, and the broader healthcare infrastructure. Increasing global healthcare spending, a rise in chronic disease prevalence, and expanding access to diagnostic services in emerging markets contribute to steady growth for meglumine. Additionally, regulatory emphasis on high-purity pharmaceutical ingredients has enhanced the importance of reliable supply and quality standards in this market.

From a competitive standpoint, the market is relatively consolidated, with production concentrated among a limited number of specialized chemical manufacturers. Pricing dynamics are influenced by raw material costs and the stringent compliance requirements for pharmaceutical-grade compounds. Growth opportunities are seen in Asia-Pacific, where expanding pharmaceutical manufacturing capacity and rising demand for contrast media in medical imaging are boosting consumption. However, market expansion may face challenges from substitution by alternative excipients, fluctuating supply chains, and compliance hurdles for manufacturers seeking entry into regulated markets such as the U.S. and Europe.

This report presents a comprehensive overview of the global Meglumine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Diatrizoate Meglumine
• Lothalamate Meglumine
• Lodipamide Meglumine

Segment by Application

• Cosolvent
• Contrast agent
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Meglumine market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Cosolvent, Contrast agent, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact